Catheter Precision (VTAK)

• Market cap: $3.51M
• 1 day: -2.72%
• 5 days: -6.23%
• 1 month: -30.58%
• 3 months: -19.89%
• 6 months: -56.34%
• Year to date: -66.47%
• 1 year: -91.95%
• 5 years: -100.00%
• 10 years: -100.00%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

Employees: 22

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

20% more funds holding

Funds holding: 10 [Q1] → 12 (+2) [Q2]

3.4% less ownership

Funds ownership: 7.34% [Q1] → 3.95% (-3.4%) [Q2]

41% less capital invested

Capital invested by funds: $202K [Q1] → $120K (-$82.1K) [Q2]